No Data
No Data
CRISPR Therapeutics (NASDAQ:CRSP) Is In A Good Position To Deliver On Growth Plans
CRISPR Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference
Bluebird Bio Stock Slides for Second Day on Buyout News
Insider Sale: Chief Executive Officer of $CRSP Sells 18,360 Shares
HIMS Jumps 174% YTD — Who's Next?
CRISPR Set to Snap Six Days of Gains as Shares Trade in Red
sooogod : nbis.
GOGOY : Tem will be the next